Month: November 2018

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antibiotics, Acid Suppressants in Infancy May Up […]

Here are what the editors at HealthDay consider to be the most important developments in Neurology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Link Between Statins, Non-CVD Outcomes Lacks Evidence WEDNESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Nursing for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Opioid Use Often Persists in Workers’ Compensation Claimants […]

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Black, Low-Income Women May Not […]

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Barriers to Prostate Cancer Research in […]

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. 50 Percent of Children Aged 2 to 5 […]

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Opioid Use Often Persists in Workers’ Compensation Claimants […]

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Link Between Statins, Non-CVD Outcomes Lacks Evidence WEDNESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Surgery for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Greater Weight Loss With Gastric Bypass Than Other […]

Here are what the editors at HealthDay consider to be the most important developments in Urology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Barriers to Prostate Cancer Research in Black Men […]

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Greater Weight Loss With Gastric Bypass Than […]

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training […]

Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Sub-Concussive Hits May Not Be Tied to […]

Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AMA Announces Initiative to Reinvent Physician Training TUESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Link Between Statins, Non-CVD Outcomes Lacks Evidence WEDNESDAY, […]

Here are what the editors at HealthDay consider to be the most important developments in Pathology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Barriers to Prostate Cancer Research in Black Men […]

Here are what the editors at HealthDay consider to be the most important developments in Radiology for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Black, Low-Income Women May Not Report Barriers to […]